Market Overview: The global market for Human Immunodeficiency Virus (HIV-1) therapeutics reached a value of USD 27.3 Billion in 2022 and is projected to achieve USD 42.35 Billion by 2032, with a compound annual growth rate (CAGR) of 5% during the forecast period. This growth is attributed to various factors, including the increasing prevalence of HIV infections worldwide and the growing demand...